Celgene pops after top proxy advisors recommend Bristol-Myers investors approve buyout

Institutional Shareholder Services recommends Bristol-Myers Squibb shareholders vote in favor of its bid to buy Celgene.

from U.S. News https://ift.tt/2FBvrvp